7/7/2020  12:56:49 PM Chg. -0.080 Volume Bid1:17:17 PM Ask1:17:17 PM Market Capitalization Dividend Y. P/E Ratio
1.060EUR -7.02% 8,166
Turnover: 8,776.920
1.060Bid Size: 750 1.070Ask Size: 542 9.33 mill.EUR - -

Business description

NanoRepro AG is an innovative leader in the development, manufacturing and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use, in the domestic and international markets. Since October 2008, NanoRepro has been publicly listed with its headquarters located in Marburg, Germany.
 

Management board & Supervisory board

CEO
Lisa Jüngst
Management board
Michael Fuchs
Supervisory board
Dr. Olaf Stiller, Michael J. Tillmann, Clemens Jakopitsch, Dr. Bhuwnesh Agrawal, Dr. Michael Kern
 

Company data

Name: NanoRepro AG
Address: Untergasse 8,D-35037 Marburg
Phone: +49-6421-951449
Fax: +49-6421-951451
E-mail: info@nano.ag
Internet: www.nano.ag
Industry: -
Sector: -
Sub sector: -
End of financial year: 12/31
Free Float: 88.00%
IPO date: -

Investor relations

Name: Michael Fuchs
IR phone: -
IR Fax: -
IR e-mail: fuchs@nanorepro.com

Main Shareholders

Freefloat
 
88.00%
Management
 
12.00%